10-Q · 2026-11-05
Caribou Biosciences releases its Q3 results, showcasing financial performance and future strategies in the biological products sector.
| Name | Caribou Biosciences, Inc. |
|---|---|
| CIK | 0001619856 |
| Tickers | CRBU |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 453728228 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 510-982-6030 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 1 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Caribou Biosciences releases its Q3 results, showcasing financial performance and future strategies in the biological products sector.
326 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-05 | 10-Q | 10-Q | 0001619856-26-000061 | 001-40631 | 261527307 | 34 | 6828373 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001619856-26-000060 | 001-40631 | 261527270 | 34 | 292532 | 1 | 1 |
| 2026-10-06 | 8-K | 8-K | 2.05,5.02,7.01,8.01,9.01 | 0001193125-26-415559 | 001-40631 | 261444076 | 34 | 190346 | 1 | 1 |
| 2026-08-13 | 10-Q | 10-Q | 0001619856-26-000055 | 001-40631 | 261273464 | 34 | 6649436 | 1 | 1 | |
| 2026-08-13 | 8-K | 8-K | 2.02,9.01 | 0001619856-26-000053 | 001-40631 | 261273307 | 34 | 315408 | 1 | 1 |
| 2026-07-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002279 | 005-92726 | 261206163 | 34 | 10827 | |||
| 2026-06-18 | 8-K | 8-K | 5.07,9.01 | 0001619856-26-000047 | 001-40631 | 261102417 | 34 | 166236 | 1 | 1 |
| 2026-06-11 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-26-000043 | 001-40631 | 261081478 | 34 | 381188 | 1 | 1 |
| 2026-06-05 | DEFA14A | DEFA14A | 0001619856-26-000039 | 001-40631 | 261068913 | 34 | 290427 | |||
| 2026-05-07 | 10-Q | 10-Q | 0001619856-26-000036 | 001-40631 | 26953474 | 34 | 5944540 | 1 | 1 | |
| 2026-05-07 | 8-K | 8-K | 2.02,9.01 | 0001619856-26-000035 | 001-40631 | 26953324 | 34 | 295557 | 1 | 1 |
| 2026-05-01 | DEFR14A | DEFR14A | 0001619856-26-000028 | 001-40631 | 26932353 | 34 | 2263728 | 1 | 1 | |
| 2026-04-24 | ARS | ARS | 0001619856-26-000024 | 001-40631 | 26893495 | 34 | 60316623 | |||
| 2026-04-24 | DEFA14A | DEFA14A | 0001619856-26-000023 | 001-40631 | 26893461 | 34 | 437744 | |||
| 2026-04-24 | DEF 14A | DEF 14A | 0001619856-26-000022 | 001-40631 | 26893456 | 34 | 2258088 | 1 | 1 | |
| 2026-04-10 | PRE 14A | PRE 14A | 0001619856-26-000015 | 001-40631 | 26854767 | 34 | 2259803 | 1 | 1 | |
| 2026-03-31 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-26-000012 | 001-40631 | 26817119 | 34 | 249523 | 1 | 1 |
| 2026-03-05 | S-8 | S-8 | 0001193125-26-094237 | 333-294065 | 26727334 | 33 | 192777 | 1 | 1 | |
| 2026-03-05 | 10-K | 10-K | 0001619856-26-000008 | 001-40631 | 26726173 | 34 | 21794160 | 1 | 1 | |
| 2026-03-05 | 8-K | 8-K | 2.02,9.01 | 0001619856-26-000007 | 001-40631 | 26726140 | 34 | 338544 | 1 | 1 |
| 2026-02-27 | 4 | FORM 4 | 0001754067-26-000004 | 4540 | ||||||
| 2026-02-25 | 144 | xsl144X01/primary_doc.xml | 0001891113-26-000005 | 001-40631 | 26681381 | 33 | 4793 | |||
| 2026-02-25 | 144 | xsl144X01/primary_doc.xml | 0001231321-26-000007 | 001-40631 | 26681380 | 33 | 4800 | |||
| 2026-02-25 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-001807 | 001-40631 | 26680188 | 33 | 5361 | |||
| 2026-02-24 | 4 | FORM 4 | 0001754067-26-000002 | 9096 | ||||||
| 2026-02-24 | 4 | FORM 4 | 0001231321-26-000002 | 9435 | ||||||
| 2026-02-24 | 4 | FORM 4 | 0001891113-26-000002 | 9459 | ||||||
| 2026-02-24 | 4 | FORM 4 | 0001917391-26-000002 | 9459 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001885914-26-000002 | 5399 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001880609-26-000002 | 5407 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001683811-26-000002 | 5434 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001893193-26-000003 | 5442 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001733883-26-000004 | 5468 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001230724-26-000004 | 5451 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001643875-26-000004 | 5463 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001762893-26-000002 | 7284 | ||||||
| 2026-02-20 | 4 | FORM 4 | 0001670579-26-000002 | 8425 | ||||||
| 2025-11-12 | 10-Q | 10-Q | 0001619856-25-000071 | 001-40631 | 251472767 | 34 | 7236458 | 1 | 1 | |
| 2025-11-12 | 8-K | 8-K | 2.02,9.01 | 0001619856-25-000070 | 001-40631 | 251472713 | 34 | 320426 | 1 | 1 |
| 2025-11-03 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001619856-25-000065 | 001-40631 | 251442076 | 34 | 14404045 | 1 | 1 |
| 2025-08-12 | 10-Q | 10-Q | 0001619856-25-000061 | 001-40631 | 251206738 | 34 | 7133666 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,9.01 | 0001619856-25-000060 | 001-40631 | 251206697 | 34 | 330265 | 1 | 1 |
| 2025-07-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002538 | 005-92726 | 251128476 | 34 | 10746 | |||
| 2025-06-23 | 8-K | 8-K | 8.01 | 0001619856-25-000052 | 001-40631 | 251062999 | 34 | 145446 | 1 | 1 |
| 2025-06-13 | 8-K | 8-K | 5.07,9.01 | 0001619856-25-000047 | 001-40631 | 251046334 | 34 | 166157 | 1 | 1 |
| 2025-05-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001609 | 333-287093 | 25948292 | 33 | 1744 | ||
| 2025-05-13 | CORRESP | filename1.htm | 0001193125-25-119050 | 6364 | ||||||
| 2025-05-12 | UPLOAD | filename1.pdf | 0000000000-25-005015 | 333-287093 | 40133 | |||||
| 2025-05-08 | DEFA14A | DEFA14A | 0001619856-25-000044 | 001-40631 | 25927263 | 34 | 296836 | |||
| 2025-05-08 | S-3 | S-3 | 0001193125-25-116051 | 333-287093 | 25927150 | 33 | 1227947 | |||
| 2025-05-08 | 10-Q | 10-Q | 0001619856-25-000043 | 001-40631 | 25926480 | 34 | 6608068 | 1 | 1 | |
| 2025-05-08 | 8-K | 8-K | 2.02,9.01 | 0001619856-25-000040 | 001-40631 | 25926006 | 34 | 293870 | 1 | 1 |
| 2025-04-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000487 | 005-92726 | 25891962 | 34 | 6251 | |||
| 2025-04-25 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0000950170-25-058810 | 005-92726 | 25874809 | 34 | 188123 | |||
| 2025-04-25 | ARS | ARS | 0001619856-25-000033 | 001-40631 | 25873759 | 34 | 61377261 | |||
| 2025-04-25 | DEFA14A | DEFA14A | 0001619856-25-000032 | 001-40631 | 25873719 | 34 | 440923 | |||
| 2025-04-25 | DEF 14A | DEF 14A | 0001619856-25-000031 | 001-40631 | 25873667 | 34 | 2148988 | 1 | 1 | |
| 2025-04-24 | 8-K | 8-K | 2.02,2.05,8.01,9.01 | 0001619856-25-000023 | 001-40631 | 25867565 | 34 | 276885 | 1 | 1 |
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000713 | 005-92726 | 25844666 | 34 | 10832 | |||
| 2025-04-11 | PRE 14A | PRE 14A | 0001619856-25-000019 | 001-40631 | 25831511 | 34 | 1976515 | 1 | 1 | |
| 2025-03-17 | 4 | FORM 4 | 0001670579-25-000008 | 6009 | ||||||
| 2025-03-10 | S-8 | S-8 | 0001193125-25-051061 | 333-285685 | 25724547 | 33 | 77301 | |||
| 2025-03-10 | 10-K | 10-K | 0001619856-25-000015 | 001-40631 | 25723765 | 34 | 13384123 | 1 | 1 | |
| 2025-03-10 | 8-K | 8-K | 2.02,9.01 | 0001619856-25-000014 | 001-40631 | 25723730 | 34 | 326022 | 1 | 1 |
| 2025-02-21 | 4 | FORM 4 | 0001670579-25-000003 | 8202 | ||||||
| 2025-02-21 | 4 | FORM 4 | 0001917391-25-000003 | 7301 | ||||||
| 2025-02-21 | 4 | FORM 4 | 0001231321-25-000003 | 9961 | ||||||
| 2025-02-21 | 4 | FORM 4 | 0001891113-25-000003 | 9983 | ||||||
| 2025-02-21 | 4 | FORM 4 | 0001754067-25-000003 | 7293 | ||||||
| 2025-02-21 | 4 | FORM 4 | 0001871131-25-000003 | 10172 | ||||||
| 2025-02-21 | 4 | FORM 4 | 0001885914-25-000003 | 5406 | ||||||
| 2025-02-21 | 4 | FORM 4 | 0001880609-25-000003 | 5414 | ||||||
| 2025-02-21 | 4 | FORM 4 | 0001683811-25-000003 | 5441 | ||||||
| 2025-02-21 | 4 | FORM 4 | 0001893193-25-000004 | 5449 | ||||||
| 2025-02-21 | 4 | FORM 4 | 0001733883-25-000003 | 5475 | ||||||
| 2025-02-21 | 4 | FORM 4 | 0001230724-25-000003 | 5458 | ||||||
| 2025-02-21 | 4 | FORM 4 | 0001643875-25-000003 | 5470 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000070858-25-000122 | 005-92726 | 25631481 | 34 | 27612 | |||
| 2025-01-30 | 4 | FORM 4 | 0001762893-25-000009 | 4547 | ||||||
| 2025-01-13 | 8-K | 8-K | 7.01,9.01 | 0001619856-25-000006 | 001-40631 | 25524865 | 34 | 277039 | 1 | 1 |
| 2025-01-10 | 4 | FORM 4 | 0001762893-25-000006 | 5569 | ||||||
| 2025-01-10 | 3 | FORM 3 | 0001762893-25-000005 | 335458 | ||||||
| 2025-01-02 | 8-K | 8-K | 5.02,7.01,9.01 | 0001619856-25-000002 | 001-40631 | 25500279 | 34 | 754800 | 1 | 1 |
| 2024-12-06 | SC 13D/A | SC 13D/A | 0001193125-24-272453 | 005-92726 | 241532319 | 34 | 69168 | |||
| 2024-11-22 | 4 | FORM 4 | 0001871155-24-000005 | 4909 | ||||||
| 2024-11-14 | SC 13G/A | p24-3175sc13ga.htm | 0000902664-24-006658 | 005-92726 | 241465318 | 34 | 99209 | |||
| 2024-11-14 | SC 13G/A | d11530039_13g-a.htm | 0000919574-24-006775 | 005-92726 | 241464898 | 34 | 177901 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-118872 | 005-92726 | 241461680 | 34 | 149461 | |||
| 2024-11-14 | SC 13G | doc1.htm | 0000070858-24-000323 | 005-92726 | 241459077 | 34 | 91916 | |||
| 2024-11-12 | SC 13G/A | UnitedStates_13G__CaribouBio.txt | 0000932471-24-000855 | 005-92726 | 241446487 | 34 | 6544 | |||
| 2024-11-06 | 10-Q | 10-Q | 0001619856-24-000081 | 001-40631 | 241430962 | 34 | 8001286 | 1 | 1 | |
| 2024-11-06 | 8-K | 8-K | 2.02,9.01 | 0001619856-24-000080 | 001-40631 | 241430937 | 34 | 328379 | 1 | 1 |
| 2024-11-04 | SC 13G/A | UnitedStates_13G__CaribouBio.txt | 0000932471-24-000315 | 005-92726 | 241421459 | 34 | 5602 | |||
| 2024-10-17 | SC 13G/A | Caribou_Biosciences_Inc.htm | 0000093751-24-000817 | 005-92726 | 241376682 | 34 | 55853 | |||
| 2024-10-04 | 3 | FORM 3 | 0001871155-24-000003 | 343335 | ||||||
| 2024-09-27 | 8-K/A | 8-K/A | 5.02,9.01 | 0001619856-24-000074 | 001-40631 | 241334820 | 34 | 159100 | 1 | 1 |
| 2024-09-03 | 8-K | 8-K | 5.02 | 0001619856-24-000071 | 001-40631 | 241273925 | 34 | 158866 | 1 | 1 |
| 2024-08-20 | 4 | FORM 4 | 0001917391-24-000009 | 5545 | ||||||
| 2024-08-20 | 3 | FORM 3 | 0001917391-24-000008 | 339655 | ||||||
| 2024-08-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-24-000068 | 001-40631 | 241194790 | 34 | 282828 | 1 | 1 |
| 2024-08-06 | 10-Q | 10-Q | 0001619856-24-000064 | 001-40631 | 241179238 | 34 | 7189737 | 1 | 1 | |
| 2024-08-06 | 8-K | 8-K | 2.02,9.01 | 0001619856-24-000063 | 001-40631 | 241179195 | 34 | 330892 | 1 | 1 |
| 2024-07-16 | 8-K | 8-K | 2.02,2.05,9.01 | 0001619856-24-000054 | 001-40631 | 241119683 | 34 | 164447 | 1 | 1 |
| 2024-06-14 | 8-K | 8-K | 5.07,9.01 | 0001619856-24-000050 | 001-40631 | 241044639 | 34 | 165723 | 1 | 1 |
| 2024-06-03 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-24-000046 | 001-40631 | 241011869 | 34 | 9849355 | 1 | 1 |
| 2024-05-07 | 10-Q | 10-Q | 0001619856-24-000038 | 001-40631 | 24922067 | 34 | 6727360 | 1 | 1 | |
| 2024-05-07 | 8-K | 8-K | 2.02,9.01 | 0001619856-24-000036 | 001-40631 | 24921952 | 34 | 305892 | 1 | 1 |
| 2024-04-25 | ARS | ARS | 0001619856-24-000028 | 001-40631 | 24876254 | 34 | 62385894 | |||
| 2024-04-25 | DEFA14A | DEFA14A | 0001619856-24-000027 | 001-40631 | 24876153 | 34 | 391912 | |||
| 2024-04-25 | DEF 14A | DEF 14A | 0001619856-24-000026 | 001-40631 | 24876124 | 34 | 1129408 | |||
| 2024-04-04 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-24-000018 | 001-40631 | 24823163 | 34 | 3504862 | 1 | 1 |
| 2024-03-11 | S-8 | S-8 | 0001193125-24-064948 | 333-277827 | 24739031 | 33 | 78148 | |||
| 2024-03-11 | 10-K | 10-K | 0001619856-24-000013 | 001-40631 | 24738392 | 34 | 19874634 | 1 | 1 | |
| 2024-03-11 | 8-K | 8-K | 2.02,9.01 | 0001619856-24-000012 | 001-40631 | 24738333 | 34 | 326793 | 1 | 1 |
| 2024-02-23 | SC 13G | CARIBOU BIOSCIENCES, INC. | 0000902664-24-001995 | 005-92726 | 24671373 | 34 | 113181 | |||
| 2024-02-22 | 4 | FORM 4 | 0001628280-24-006433 | 7506 | ||||||
| 2024-02-22 | 4 | FORM 4 | 0001628280-24-006429 | 7299 | ||||||
| 2024-02-22 | 4 | FORM 4 | 0001628280-24-006425 | 7302 | ||||||
| 2024-02-22 | 4 | FORM 4 | 0001628280-24-006421 | 8202 | ||||||
| 2024-02-22 | 4 | FORM 4 | 0001628280-24-006419 | 7297 | ||||||
| 2024-02-22 | 4 | FORM 4 | 0001628280-24-006416 | 5406 | ||||||
| 2024-02-22 | 4 | FORM 4 | 0001628280-24-006414 | 5414 | ||||||
| 2024-02-22 | 4 | FORM 4 | 0001628280-24-006412 | 5441 | ||||||
| 2024-02-22 | 4 | FORM 4 | 0001628280-24-006411 | 5449 | ||||||
| 2024-02-22 | 4 | FORM 4 | 0001628280-24-006407 | 5475 | ||||||
| 2024-02-22 | 4 | FORM 4 | 0001628280-24-006405 | 5458 | ||||||
| 2024-02-22 | 4 | FORM 4 | 0001628280-24-006402 | 5470 | ||||||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023607 | 005-92726 | 24637904 | 34 | 150093 | |||
| 2024-02-14 | SC 13G/A | CARIBOU BIOSCIENCES, INC. | 0000902664-24-001528 | 005-92726 | 24632050 | 34 | 116893 | |||
| 2024-02-08 | 4 | FORM 4 | 0001871131-24-000002 | 6942 | ||||||
| 2024-01-25 | SC 13G/A | us1420381089_012524.txt | 0001086364-24-003817 | 005-92726 | 24563031 | 34 | 13416 | |||
| 2024-01-25 | SC 13G/A | Caribou_Bio.txt | 0000093751-24-000191 | 005-92726 | 24558570 | 34 | 8395 | |||
| 2024-01-10 | 3/A | FORM 3/A | 0001754067-24-000009 | 300841 | ||||||
| 2024-01-09 | 4 | FORM 4 | 0001754067-24-000006 | 5571 | ||||||
| 2024-01-09 | 3 | FORM 3 | 0001754067-24-000004 | 277062 | ||||||
| 2024-01-08 | SC 13G | d10927867_13-g.htm | 0000919574-24-000156 | 005-92726 | 24520379 | 34 | 197187 | |||
| 2024-01-08 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-24-000003 | 001-40631 | 24518386 | 34 | 290724 | 1 | 1 |
| 2023-12-22 | 8-K | 8-K | 5.02,9.01 | 0001619856-23-000138 | 001-40631 | 231509775 | 34 | 160517 | 1 | 1 |
| 2023-12-12 | 8-K | 8-K | 5.02,7.01,8.01,9.01 | 0001619856-23-000134 | 001-40631 | 231481242 | 34 | 261834 | 1 | 1 |
| 2023-11-17 | 10-Q/A | 10-Q/A | 0001619856-23-000130 | 001-40631 | 231418654 | 34 | 229798 | 1 | 1 | |
| 2023-11-17 | 10-Q/A | 10-Q/A | 0001619856-23-000129 | 001-40631 | 231418611 | 34 | 229747 | 1 | 1 | |
| 2023-11-07 | 10-Q | 10-Q | 0001619856-23-000124 | 001-40631 | 231383599 | 34 | 7203131 | 1 | 1 | |
| 2023-11-07 | 8-K | 8-K | 2.02,9.01 | 0001619856-23-000123 | 001-40631 | 231383569 | 34 | 323747 | 1 | 1 |
| 2023-10-18 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-23-000116 | 001-40631 | 231330943 | 34 | 364581 | 1 | 1 |
| 2023-09-26 | 8-K | 8-K | 1.02,9.01 | 0001619856-23-000112 | 001-40631 | 231280505 | 34 | 160174 | 1 | 1 |
| 2023-08-08 | 10-Q | 10-Q | 0001619856-23-000107 | 001-40631 | 231151227 | 34 | 7183858 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0001619856-23-000105 | 001-40631 | 231151111 | 34 | 326070 | 1 | 1 |
| 2023-07-20 | SC 13G | CARIBOU BIOSCIENCES, INC. | 0000902664-23-004032 | 005-92726 | 231099880 | 34 | 131784 | |||
| 2023-07-17 | 8-K | 8-K | 1.01,9.01 | 0001619856-23-000096 | 001-40631 | 231090140 | 34 | 775777 | 1 | 1 |
| 2023-07-14 | 424B5 | 424B5 | 0001193125-23-187360 | 333-266712 | 231089922 | 33 | 634163 | |||
| 2023-07-14 | 8-K/A | 8-K/A | 8.01,9.01 | 0001619856-23-000093 | 001-40631 | 231089374 | 34 | 2283632 | 1 | 1 |
| 2023-07-13 | 424B5 | 424B5 | 0001193125-23-186614 | 333-266712 | 231087266 | 33 | 603297 | |||
| 2023-07-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001619856-23-000087 | 001-40631 | 231087014 | 34 | 6847081 | 1 | 1 |
| 2023-07-13 | 8-K | 8-K | 8.01,9.01 | 0001619856-23-000084 | 001-40631 | 231086949 | 34 | 2184254 | 1 | 1 |
| 2023-07-10 | SC 13G | SC 13G CARIBOU BIOSCIENCES | 0000078003-23-000079 | 005-92726 | 231078372 | 34 | 42768 | |||
| 2023-07-06 | 8-K | 8-K | 1.01,3.02,7.01,8.01,9.01 | 0001619856-23-000079 | 001-40631 | 231072125 | 34 | 577678 | 1 | 1 |
| 2023-06-16 | 8-K | 8-K | 5.07,9.01 | 0001619856-23-000076 | 001-40631 | 231020958 | 34 | 189038 | 1 | 1 |
| 2023-06-09 | 4 | FORM 4 | 0001619856-23-000073 | 7683 | ||||||
| 2023-05-09 | 10-Q | 10-Q | 0001619856-23-000071 | 001-40631 | 23901980 | 34 | 6882564 | 1 | 1 | |
| 2023-05-09 | 8-K | 8-K | 2.02,9.01 | 0001619856-23-000070 | 001-40631 | 23901886 | 34 | 320125 | 1 | 1 |
| 2023-04-28 | ARS | ARS | 0001619856-23-000065 | 001-40631 | 23866075 | 34 | 60794026 | |||
| 2023-04-28 | DEFA14A | DEFA14A | 0001619856-23-000064 | 001-40631 | 23865970 | 34 | 373372 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0001619856-23-000063 | 001-40631 | 23865893 | 34 | 970806 | |||
| 2023-04-04 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-23-000055 | 001-40631 | 23795126 | 34 | 255117 | 1 | 1 |
| 2023-03-29 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-23-000050 | 001-40631 | 23771803 | 34 | 258441 | 1 | 1 |
| 2023-03-29 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-23-000049 | 001-40631 | 23771801 | 34 | 266242 | 1 | 1 |
| 2023-03-24 | 8-K | 8-K | 8.01,9.01 | 0001619856-23-000042 | 001-40631 | 23759879 | 34 | 161212 | 1 | 1 |
| 2023-03-22 | 4 | FORM 4 | 0001619856-23-000039 | 7729 | ||||||
| 2023-03-09 | S-8 | S-8 | 0001193125-23-066300 | 333-270431 | 23720821 | 33 | 76046 | |||
| 2023-03-09 | 10-K | 10-K | 0001619856-23-000037 | 001-40631 | 23720711 | 34 | 21702698 | 1 | 1 | |
| 2023-03-09 | 8-K | 8-K | 2.02,9.01 | 0001619856-23-000035 | 001-40631 | 23720661 | 34 | 348917 | 1 | 1 |
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000028 | 5474 | ||||||
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000027 | 5467 | ||||||
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000026 | 5421 | ||||||
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000025 | 5473 | ||||||
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000024 | 5413 | ||||||
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000023 | 5442 | ||||||
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000022 | 5430 | ||||||
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000021 | 5469 | ||||||
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000020 | 5482 | ||||||
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000019 | 5378 | ||||||
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000018 | 5386 | ||||||
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000017 | 5465 | ||||||
| 2023-02-23 | 4 | FORM 4 | 0001619856-23-000016 | 5447 | ||||||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021580 | 005-92726 | 23628970 | 34 | 122221 | |||
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001350 | 005-92726 | 23601206 | 34 | 7920 | |||
| 2023-02-03 | SC 13G | Caribou_Biosciences_Inc.txt | 0000093751-23-000161 | 005-92726 | 23585260 | 34 | 8406 | |||
| 2023-02-03 | SC 13G | us1420381089_020323.txt | 0001306550-23-007127 | 005-92726 | 23584766 | 34 | 13218 | |||
| 2023-01-20 | 4 | FORM 4 | 0001619856-23-000002 | 4795 | ||||||
| 2022-12-16 | 8-K | 8-K | 5.02,9.01 | 0001619856-22-000039 | 001-40631 | 221467958 | 34 | 181234 | 1 | 1 |
| 2022-12-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-22-000036 | 001-40631 | 221456180 | 34 | 470163 | 1 | 1 |
| 2022-12-02 | 4 | FORM 4 | 0001619856-22-000031 | 6875 | ||||||
| 2022-11-29 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-22-000029 | 001-40631 | 221428634 | 34 | 277166 | 1 | 1 |
| 2022-11-21 | 8-K | 8-K | 7.01,8.01,9.01 | 0001619856-22-000025 | 001-40631 | 221403642 | 34 | 605440 | 1 | 1 |
| 2022-11-08 | 10-Q | 10-Q | 0001619856-22-000022 | 001-40631 | 221369256 | 34 | 8902424 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0001619856-22-000019 | 001-40631 | 221368837 | 34 | 339594 | 1 | 1 |
| 2022-11-03 | 8-K | 8-K | 7.01,9.01 | 0001619856-22-000010 | 001-40631 | 221356448 | 34 | 274010 | 1 | 1 |
| 2022-10-18 | 8-K | 8-K | 7.01,9.01 | 0001619856-22-000007 | 001-40631 | 221315014 | 34 | 278938 | 1 | 1 |
| 2022-10-07 | 4 | FORM 4 | 0001619856-22-000003 | 13073 | ||||||
| 2022-09-23 | 8-K/A | 8-K/A | 5.07,9.01 | 0000950170-22-018793 | 001-40631 | 221260311 | 34 | 209190 | 1 | 1 |
| 2022-09-22 | 8-K | 8-K | 5.07,9.01 | 0000950170-22-018768 | 001-40631 | 221259289 | 34 | 201942 | 1 | 1 |
| 2022-09-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-050315 | 10897 | ||||||
| 2022-08-26 | 4 | FORM 4 SUBMISSION | 0001209191-22-047748 | 9457 | ||||||
| 2022-08-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-047370 | 5482 | ||||||
| 2022-08-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-047368 | 4960 | ||||||
| 2022-08-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-08-16 16:00:00 | 9999999995-22-002403 | 333-266712 | 221171943 | 33 | 1703 | ||
| 2022-08-12 | CORRESP | filename1.htm | 0001193125-22-219961 | 6092 | ||||||
| 2022-08-12 | 8-K | 8-K | 1.01,9.01 | 0000950170-22-017117 | 001-40631 | 221159905 | 34 | 184567 | 1 | 1 |
| 2022-08-11 | UPLOAD | filename1.pdf | 0000000000-22-008557 | 40240 | ||||||
| 2022-08-11 | DEFA14A | DEFA14A | 0000950170-22-016867 | 001-40631 | 221155801 | 34 | 1469072 | |||
| 2022-08-11 | DEFA14A | DEFA14A | 0000950170-22-016855 | 001-40631 | 221155699 | 34 | 69742 | |||
| 2022-08-11 | DEF 14A | DEF 14A | 0000950170-22-016847 | 001-40631 | 221155621 | 34 | 1304578 | |||
| 2022-08-09 | S-3 | S-3 | 0001193125-22-216271 | 333-266712 | 221149157 | 33 | 1420568 | |||
| 2022-08-09 | 10-Q | 10-Q | 0000950170-22-016053 | 001-40631 | 221148409 | 34 | 13479103 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-22-016031 | 001-40631 | 221148180 | 34 | 577883 | 1 | 1 |
| 2022-07-18 | 8-K/A | 8-K/A | 5.02 | 0000950170-22-012759 | 001-40631 | 221089229 | 34 | 168649 | 1 | 1 |
| 2022-07-15 | 8-K | 8-K | 8.01 | 0000950170-22-012732 | 001-40631 | 221086370 | 34 | 161855 | 1 | 1 |
| 2022-06-10 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-22-011433 | 001-40631 | 221007653 | 34 | 3731964 | 1 | 1 |
| 2022-06-01 | SC 13G/A | SC 13G/A | 0001193125-22-165343 | 005-92726 | 22988383 | 34 | 37578 | |||
| 2022-06-01 | 8-K | 8-K | 7.01,9.01 | 0000950170-22-011024 | 001-40631 | 22987489 | 34 | 234787 | 1 | 1 |
| 2022-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-030288 | 5284 | ||||||
| 2022-05-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-029893 | 11571 | ||||||
| 2022-05-12 | 3 | FORM 3 SUBMISSION | 0001209191-22-028617 | 6299 | ||||||
| 2022-05-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-22-009499 | 001-40631 | 22916182 | 34 | 2424698 | 1 | 1 |
| 2022-05-11 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-22-009315 | 001-40631 | 22913741 | 34 | 278628 | 1 | 1 |
| 2022-05-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-028170 | 8391 | ||||||
| 2022-05-10 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-028169 | 8988 | ||||||
| 2022-05-09 | 10-Q | 10-Q | 0000950170-22-008513 | 001-40631 | 22905390 | 34 | 12015742 | 1 | 1 | |
| 2022-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-008491 | 001-40631 | 22905041 | 34 | 427178 | 1 | 1 |
| 2022-05-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-027696 | 11753 | ||||||
| 2022-04-25 | 8-K | 8-K | 7.01 | 0000950170-22-006094 | 001-40631 | 22849917 | 34 | 272454 | 1 | 1 |
| 2022-03-21 | S-8 | S-8 CRBU 2022 | 0001564590-22-011219 | 333-263750 | 22756358 | 33 | 177499 | |||
| 2022-03-21 | 10-K | 10-K | 0000950170-22-004233 | 001-40631 | 22755924 | 34 | 34762234 | 1 | 1 | |
| 2022-03-21 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-004230 | 001-40631 | 22755832 | 34 | 491642 | 1 | 1 |
| 2022-03-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-019808 | 11963 | ||||||
| 2022-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-016872 | 11770 | ||||||
| 2022-03-01 | SC 13G | SC 13G | 0001193125-22-061426 | 005-92726 | 22698969 | 34 | 39803 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-022219 | 005-92726 | 22628172 | 34 | 140575 | |||
| 2022-02-11 | SC 13G/A | AMENDMENT #1 | 0000908834-22-000085 | 005-92726 | 22618863 | 34 | 390552 | |||
| 2022-02-09 | 5 | FORM 5 SUBMISSION | 0001209191-22-008027 | 6824 | ||||||
| 2022-02-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-007860 | 7186 | ||||||
| 2022-02-04 | SC 13D | SC 13D | 0000950170-22-000764 | 005-92726 | 22591147 | 34 | 159632 | |||
| 2022-01-27 | 4 | FORM 4 SUBMISSION | 0001209191-22-005222 | 7461 | ||||||
| 2022-01-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-004860 | 7545 | ||||||
| 2022-01-24 | 3 | FORM 3 SUBMISSION | 0001209191-22-004600 | 7451 | ||||||
| 2022-01-19 | 8-K | 8-K | 1.01,2.03,9.01 | 0000950170-22-000401 | 001-40631 | 22539009 | 34 | 1589905 | 1 | 1 |
| 2022-01-18 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-000354 | 001-40631 | 22533668 | 34 | 276061 | 1 | 1 |
| 2022-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-003062 | 11562 | ||||||
| 2021-12-22 | 4/A | FORM 4/A SUBMISSION | 0001209191-21-071011 | 5930 | ||||||
| 2021-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-070829 | 5407 | ||||||
| 2021-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-070825 | 5416 | ||||||
| 2021-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-070823 | 5442 | ||||||
| 2021-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-070819 | 5537 | ||||||
| 2021-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-070814 | 5541 | ||||||
| 2021-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-070810 | 5539 | ||||||
| 2021-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-070804 | 5546 | ||||||
| 2021-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-070799 | 5412 | ||||||
| 2021-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-070797 | 10011 | ||||||
| 2021-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-070795 | 5472 | ||||||
| 2021-12-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-068582 | 11559 | ||||||
| 2021-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-21-064866 | 5581 | ||||||
| 2021-11-15 | 4 | FORM 4 SUBMISSION | 0001209191-21-064491 | 5265 | ||||||
| 2021-11-10 | 3 | FORM 3 SUBMISSION | 0001209191-21-063906 | 6238 | ||||||
| 2021-11-09 | 10-Q | 10-Q | 0000950170-21-003759 | 001-40631 | 211392536 | 34 | 11776975 | 1 | 1 | |
| 2021-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-003749 | 001-40631 | 211392271 | 34 | 465958 | 1 | 1 |
| 2021-11-08 | 3 | FORM 3 SUBMISSION | 0001209191-21-063404 | 6341 | ||||||
| 2021-11-08 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-21-003322 | 001-40631 | 211386733 | 34 | 207932 | 1 | 1 |
| 2021-10-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-061294 | 11814 | ||||||
| 2021-10-13 | 4 | FORM 4 SUBMISSION | 0001209191-21-060424 | 15121 | ||||||
| 2021-10-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-060289 | 7475 | ||||||
| 2021-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-21-058926 | 5187 | ||||||
| 2021-10-01 | 3 | FORM 3 SUBMISSION | 0001209191-21-058562 | 6436 | ||||||
| 2021-09-29 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-21-001925 | 001-40631 | 211291852 | 34 | 276711 | 1 | 1 |
| 2021-09-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-055280 | 8539 | ||||||
| 2021-09-02 | 10-Q | 10-Q | 0000950170-21-001660 | 001-40631 | 211233591 | 34 | 11812998 | 1 | 1 | |
| 2021-09-02 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-001658 | 001-40631 | 211233458 | 34 | 450446 | 1 | 1 |
| 2021-08-31 | 3 | FORM 3 SUBMISSION | 0001209191-21-054086 | 6337 | ||||||
| 2021-08-25 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-21-001559 | 001-40631 | 211207021 | 34 | 265323 | 1 | 1 |
| 2021-08-06 | SC 13G | SC 13G | 0001104659-21-101539 | 005-92726 | 211153704 | 34 | 138968 | |||
| 2021-08-03 | SC 13G | SC 13G | 0001104659-21-099583 | 005-92726 | 211141223 | 34 | 443236 | |||
| 2021-07-29 | SC 13G | filing.txt | 0000315066-21-001646 | 005-92726 | 211126774 | 34 | 7524 | |||
| 2021-07-29 | 4 | PRIMARY DOCUMENT | 0000315066-21-001645 | 20846 | ||||||
| 2021-07-28 | 8-K | 8-K | 3.02,5.02,5.03,8.01,9.01 | 0001193125-21-227378 | 001-40631 | 211122580 | 34 | 422186 | ||
| 2021-07-26 | S-8 | S-8 | 0001193125-21-224325 | 333-258173 | 211114310 | 33 | 527415 | |||
| 2021-07-23 | 424B4 | 424B4 | 0001193125-21-223038 | 333-257604 | 211111110 | 33 | 5653687 | |||
| 2021-07-23 | 3 | FORM 3 SUBMISSION | 0000899243-21-029606 | 9998 | ||||||
| 2021-07-22 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-07-22 16:00:00 | 9999999995-21-002886 | 333-257604 | 211108953 | 33 | 1703 | ||
| 2021-07-22 | S-1MEF | S-1MEF | 0001193125-21-222147 | 333-258105 | 211108928 | 33 | 60007 | |||
| 2021-07-22 | 3 | FORM 3 SUBMISSION | 0000899243-21-029587 | 11320 | ||||||
| 2021-07-22 | 3 | FORM 3 SUBMISSION | 0000899243-21-029586 | 7873 | ||||||
| 2021-07-22 | 3 | FORM 3 SUBMISSION | 0000899243-21-029585 | 12205 | ||||||
| 2021-07-22 | 3 | FORM 3 SUBMISSION | 0000899243-21-029582 | 9610 | ||||||
| 2021-07-22 | 3 | FORM 3 SUBMISSION | 0000899243-21-029580 | 7930 | ||||||
| 2021-07-22 | 3 | FORM 3 SUBMISSION | 0000899243-21-029579 | 2908 | ||||||
| 2021-07-22 | 3 | FORM 3 SUBMISSION | 0000899243-21-029578 | 9989 | ||||||
| 2021-07-22 | 3 | FORM 3 SUBMISSION | 0000899243-21-029576 | 10125 | ||||||
| 2021-07-22 | 3 | PRIMARY DOCUMENT | 0000315066-21-001642 | 9952 | ||||||
| 2021-07-22 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-004268 | 271755 | ||||||
| 2021-07-22 | FWP | FWP | 0001193125-21-221335 | 333-257604 | 211105969 | 34 | 132276 | |||
| 2021-07-22 | S-1/A | S-1/A | 0001193125-21-221318 | 333-257604 | 211105919 | 33 | 5784413 | |||
| 2021-07-21 | CERT | 8ACERT_CRBU.pdf | 0001354457-21-000825 | 001-40631 | 211104333 | 34 | 996256 | |||
| 2021-07-20 | CORRESP | filename1.htm | 0001193125-21-219033 | 12432 | ||||||
| 2021-07-20 | CORRESP | filename1.htm | 0001193125-21-218918 | 6934 | ||||||
| 2021-07-19 | 8-A12B | 8-A12B | 0001193125-21-218592 | 001-40631 | 211097970 | 34 | 14144 | |||
| 2021-07-19 | S-1/A | S-1/A | 0001193125-21-217974 | 333-257604 | 211096778 | 33 | 6736170 | |||
| 2021-07-12 | CORRESP | filename1.htm | 0001193125-21-212757 | 92783 | ||||||
| 2021-07-01 | CORRESP | filename1.htm | 0001193125-21-206273 | 33722 | ||||||
| 2021-07-01 | S-1 | S-1 | 0001193125-21-206262 | 333-257604 | 211065853 | 33 | 10111047 | |||
| 2021-06-23 | UPLOAD | filename1.pdf | 0000000000-21-007723 | 46912 | ||||||
| 2021-06-11 | DRSLTR | filename1.htm | 0000950123-21-007772 | 66272 | ||||||
| 2021-06-11 | DRS/A | filename1.htm | 0000950123-21-007771 | 377-04806 | 211011144 | 33 | 6783170 | |||
| 2021-06-02 | UPLOAD | filename1.pdf | 0000000000-21-006847 | 61832 | ||||||
| 2021-05-18 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-002899 | 272615 | ||||||
| 2021-05-07 | DRS | filename1.htm | 0000950123-21-005591 | 377-04806 | 21903519 | 33 | 9096325 | |||
| 2021-03-05 | D | xslFormDX01/primary_doc.xml | 06b | 0001619856-21-000002 | 021-391380 | 21717905 | 33 | 12425 | ||
| 2019-03-25 | SC 13G/A | AMENDMENT NO. 3 | 0001654954-19-003213 | 90507 | ||||||
| 2019-01-16 | SC 13G/A | AMENDMENT NO. 2 | 0001654954-19-000534 | 85846 | ||||||
| 2018-02-06 | SC 13G/A | PRIMARY DOCUMENT | 0001654954-18-001121 | 86519 | ||||||
| 2018-01-30 | 4 | xslF345X03/form4-01302018_020115.xml | 0001415889-18-000152 | 001-37766 | 18560212 | 34 | 5954 | |||
| 2017-09-13 | 4 | xslF345X03/form4-09132017_030948.xml | 0001415889-17-001484 | 001-37766 | 171084091 | 34 | 5565 | |||
| 2017-02-28 | SC 13G | SCHEDULE 13G | 0001654954-17-001508 | 86352 | ||||||
| 2016-05-25 | D | xslFormDX01/primary_doc.xml | 06b | 0001619856-16-000005 | 021-263801 | 161673287 | 33 | 11343 | ||
| 2016-05-11 | 4 | FORM 4 SUBMISSION | 0001209191-16-119294 | 001-37766 | 161641203 | 34 | 13282 | |||
| 2016-05-05 | 3 | FORM 3 SUBMISSION | 0001209191-16-117931 | 001-37766 | 161625417 | 34 | 17398 | |||
| 2015-03-24 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001619856-15-000001 | 021-225136 | 15721793 | 33 | 9099 | ||
| 2014-09-23 | D | xslFormDX01/primary_doc.xml | 06b | 0001619856-14-000001 | 021-225136 | 141114969 | 33 | 7405 |
One latest value per concept from companyfacts (300 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 108.04M | 2026-11-02 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 112.50M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 5.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AccountsPayableRelatedPartiesCurrent | Accounts Payable, Related Parties, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0000950170-22-004233 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 518,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 535,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 5,000 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-02 | 0000950170-21-001660 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 13.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 13.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AccruedLiabilitiesCurrentAndNoncurrent | Accrued Liabilities | USD | 400,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 407,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0000950170-21-003759 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 13.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1 | Accumulated Depreciation, Depletion and Amortization, Reclassifications from Property, Plant and Equipment | USD | 1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -80,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 749.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.16M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 1.20M | 2021-06-01 | 2021-06-30 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 7.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | AllowanceForDoubtfulOtherReceivablesCurrent | Allowance for Doubtful Other Receivables, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 17.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | AreaOfRealEstateProperty | Area of Real Estate Property | sqft | 10,000 | 2022-01-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | Assets | Assets | USD | 123.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 100.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 81,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 318.56M | 2022-12-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0001619856-23-000071 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost | USD | 126.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost | USD | 3.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost | USD | 130.49M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 317.04M | 2022-12-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0001619856-23-000071 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 68.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001619856-26-000055 |
| us-gaap | CapitalizedContractCostNetCurrent | Capitalized Contract Cost, Net, Current | USD | 2.09M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016053 | |
| us-gaap | CapitalLeaseObligations | Capital Lease Obligations | USD | 100,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0000950170-22-004233 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 26.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 94.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 26.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 112.15M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016053 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 13.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | CommodityContractAssetCurrent | Commodity Contract Asset, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0000950170-22-004233 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 30.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 108.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 108.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 11,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -76.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ContractWithCustomerAssetNetCurrent | Contract with Customer, Asset, after Allowance for Credit Loss, Current | USD | 623,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 1.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 370,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 1.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 1.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 1.10M | 2018-11-30 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.03 | 2018-11-30 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | -385,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | -551,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 4.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 12.64M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016053 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016053 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 15.63M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016053 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | -166,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | DeferredTaxAssetsEquityMethodInvestments | Deferred Tax Assets, Equity Method Investments | USD | 37,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 191.19M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 30.56M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 4.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxAssetsStateTaxes | Deferred Tax Assets, State Taxes | USD | 7,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 6.64M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseOther | Deferred Tax Assets, Tax Deferred Expense, Other | USD | 801,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 1.68M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 186.92M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 548,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates | Deferred Tax Liabilities, Investment in Noncontrolled Affiliates | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 4.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | Dividends | Dividends | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | DividendsPayableCurrentAndNoncurrent | Dividends Payable | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-02 | 0000950170-21-001660 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.75 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.32 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008513 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.75 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.233 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0.01 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.015 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | 0.01 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.014 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.051 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 6.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 10.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | EquitySecuritiesFvNiGainLoss | Equity Securities, FV-NI, Gain (Loss) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ExtinguishmentOfDebtAmount | Extinguishment of Debt, Amount | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001619856-22-000022 |
| us-gaap | ExtinguishmentOfDebtGainLossNetOfTax | Extinguishment of Debt, Gain (Loss), Net of Tax | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 0 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001619856-22-000022 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | 254,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 23.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ImpairmentOfLeasehold | Impairment of Leasehold | USD | 10.00M | 2025-04-01 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -148.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -148.68M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 170,000 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001619856-23-000124 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0001619856-25-000015 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001619856-26-000036 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 34.62M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -31.22M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 2.23M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -693,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 2.03M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 7.57M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -677,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 449,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -3.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | IncreaseDecreaseInContractWithCustomerAsset | Increase (Decrease) in Contract with Customer, Asset | USD | -383,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -1.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | IncreaseDecreaseInDeferredLiabilities | Increase (Decrease) in Deferred Liabilities | USD | -548,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -2.47M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016053 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -889,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -775,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0001619856-24-000013 |
| us-gaap | IncreaseDecreaseInOtherReceivables | Increase (Decrease) in Other Receivables | USD | -1.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 573,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | InterestExpense | Interest Expense | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008513 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 148,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0000950170-22-004233 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008513 |
| us-gaap | LeaseCost | Lease, Cost | USD | 7.91M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 43.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 13.77M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 4.84M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 6.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 6.73M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 6.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 5.01M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 797,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001619856-24-000081 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 16.59M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | Liabilities | Liabilities | USD | 46.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 123.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 20.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | LinesOfCreditCurrent | Line of Credit, Current | USD | 18,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0001619856-25-000015 | |
| us-gaap | LitigationReserve | Estimated Litigation Liability | USD | 3.90M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001619856-24-000081 | |
| us-gaap | LitigationSettlementAmountAwardedToOtherParty | Litigation Settlement, Amount Awarded to Other Party | USD | 3.90M | 2024-01-01 | 2024-03-31 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001619856-24-000081 |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 0 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0000950170-22-004233 | |
| us-gaap | LongTermLoansPayable | Loans Payable, Noncurrent | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0000950170-22-004233 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 930,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0001619856-25-000015 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 227.78M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016053 | |
| us-gaap | MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 26.15M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016053 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -492,000 | 2022-04-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016053 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 23.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 62.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -72.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -75.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 3.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | NotesAndLoansPayable | Notes and Loans Payable | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0000950170-22-004233 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 84.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -79.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 7.63M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 1.80M | 2022-01-01 | 2022-01-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 27.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 24.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 4.31M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 16.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals | Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals | USD | 0 | 2021-12-31 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001619856-22-000022 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.138 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.00M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-02 | 0000950170-21-001660 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 1.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Noncontrolling Interest | USD | -492,000 | 2022-04-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016053 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -1.38M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -9,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -183,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | OtherIncome | Other Income | USD | 8.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | OtherLiabilities | Other Liabilities | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 | |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 2.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 3.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 3.39M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001619856-25-000071 | |
| us-gaap | OtherReceivables | Other Receivables | USD | 1.45M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001619856-26-000036 | |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 647,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | PaymentsForLegalSettlements | Payments for Legal Settlements | USD | 3.90M | 2024-04-22 | 2025 | Q1 | 10-Q | 2025-05-08 | 0001619856-25-000043 | |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 28.60M | 2021-07-01 | 2021-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001619856-22-000022 |
| us-gaap | PaymentsToAcquireInProcessResearchAndDevelopment | Payments to Acquire in Process Research and Development | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 300,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001619856-22-000022 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 58.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 92,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | PreferredStockLiquidationPreferenceValue | Preferred Stock, Liquidation Preference, Value | USD | 41.62M | 2020-12-31 | 2021 | Q3 | 10-Q | 2021-11-09 | 0000950170-21-003759 | |
| us-gaap | PreferredStockNoParValue | Preferred Stock, No Par Value | USD/shares | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016053 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001619856-23-000124 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001619856-23-000124 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001619856-23-000124 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001619856-23-000124 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001619856-23-000124 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 540,000 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-08 | 0001619856-25-000043 | |
| us-gaap | PrepaidRent | Prepaid Rent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 | |
| us-gaap | PrepaidTaxes | Prepaid Taxes | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0001619856-24-000013 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 22.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0001619856-25-000015 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 770,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 252.87M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | ProceedsFromOtherDebt | Proceeds from Other Debt | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0000950170-22-004233 |
| us-gaap | ProceedsFromRepaymentsOfNotesPayable | Proceeds from (Repayments of) Notes Payable | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 120.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesEquity | Proceeds from Sale of Available-for-sale Securities, Equity | USD | 7.67M | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-09 | 0000950170-21-003759 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 317,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 619,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001619856-24-000081 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -75.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 18.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 4.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | RepaymentsOfLongTermCapitalLeaseObligations | Repayments of Long-term Capital Lease Obligations | USD | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-016053 |
| us-gaap | RepaymentsOfSecuredDebt | Repayments of Secured Debt | USD | 1.15M | 2021-04-01 | 2021-06-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001619856-22-000022 |
| us-gaap | ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff | Research and Development Asset Acquired Other than Through Business Combination, Written-off | USD | 1.63M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001619856-24-000081 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 60.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost | Research and Development Expense, Software (Excluding Acquired in Process Cost) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001619856-22-000022 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 100,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminated | Restructuring and Related Cost, Number of Positions Eliminated | employee | 47 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.32 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 600,000 | 2024-07-01 | 2024-09-30 | 2024 | FY | 10-K | 2025-03-10 | 0001619856-25-000015 |
| us-gaap | RestructuringCostsAndAssetImpairmentCharges | Restructuring Costs and Asset Impairment Charges | USD | 14.43M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -672.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 5.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | RevenueFromRelatedParties | Revenue from Related Parties | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0000950170-22-004233 |
| us-gaap | RevenueNotFromContractWithCustomer | Revenue Not from Contract with Customer | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0000950170-22-004233 |
| us-gaap | RevenueRemainingPerformanceObligation | Revenue, Remaining Performance Obligation, Amount | USD | 1.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | Revenues | Revenues | USD | 0 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-02 | 0000950170-21-001660 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 2.09M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 50.00M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-02 | 0000950170-21-001660 |
| us-gaap | SecurityDeposit | Security Deposit | USD | 400,000 | 2022-01-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 1.84M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 7.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 1.14M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0001619856-24-000064 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 6.33 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0001619856-24-000064 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 78,596 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001619856-23-000124 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 10.04 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001619856-23-000124 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.758 | 2024-07-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0001619856-24-000081 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.899 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.861 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.045 | 2024-04-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0001619856-24-000064 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.046 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.038 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 6.84M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008513 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 9.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 6.18 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 1.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 2.68 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 3.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 14.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 4.86 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 14.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 4.86 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 2.99 | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-09-02 | 0000950170-21-001660 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent | Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | pure | 0.85 | 2021-07-01 | 2021-07-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.36 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 1.8 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 8.89M | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-09-02 | 0000950170-21-001660 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 0 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0000950170-22-004233 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 277,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 76.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 1.818 | 2021-07-01 | 2021-07-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | shares | 15,000 | 2024-01-01 | 2024-03-31 | 2024 | Q2 | 10-Q | 2024-08-06 | 0001619856-24-000064 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 22,206 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 150.15M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-09 | 0001619856-23-000037 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 302,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 2.68M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 2.14M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-21 | 0000950170-22-004233 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 10,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 41.32M | 2020-12-31 | 2021 | Q3 | 10-Q | 2021-11-09 | 0000950170-21-003759 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 10.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 339,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 2.06M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 305,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0001619856-24-000013 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-10 | 0001619856-25-000015 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 39.61M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 2.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-05 | 0001619856-26-000008 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 101.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 60.55M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0000950170-22-008513 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 101.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001619856-26-000061 |